一项新研究，临床医生律师病人对他们身体的活动时，看着好处 – 以及如何常规评估降低条件像癌症的风险, 糖尿病和心脏疾病.
The Center for Science in the Public Interest has downgraded it’s safety rating of the artificial sweetener sucralose for the second time in 3 years due to possible health risk. This is in response to a recently published study by an independent laboratory.
Researchers at Massachusetts General Hospital may have uncovered a novel mechanism behind the ability of the diabetes drug metformin to inhibit the progression of pancreatic cancer.
A scientific statement on endocrine-disrupting chemicals finds that they are so common that nearly every person on Earth has been exposed.